US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 5.830
  • +0.260+4.67%
Close Jan 2 16:00 ET
  • 5.830
  • 0.0000.00%
Post 20:01 ET
269.51MMarket Cap-2.05P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

4D Molecular Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 176.000K--
--2024/Q4-- / 2.201M--
--2024/Q33.000K / 601.140K--
--2024/Q25.000K / 685.710K--
--2024/Q128.000K / 915.710K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 176.000K--
--2024/Q4-- / 2.201M--
--2024/Q33.000K / 601.140K--
--2024/Q25.000K / 685.710K--
--2024/Q128.000K / 915.710K--

Unlock Free Earnings Estimates

4D Molecular Therapeutics Earnings Reports

  • 4D Molecular Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:34 ET

  • 4D Molecular Therapeutics | 8-K: 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

    Nov 13, 2024 16:23 ET

  • 4D Molecular Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:24 ET

  • 4D Molecular Therapeutics | 8-K: 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights

    Aug 8, 2024 16:23 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    New Fortress Energy
    NFE
    +7.80%
    SilverCrest Metals
    SILV
    +7.80%
    Hutchmed (China)
    HCM
    +4.65%
    Dorian LPG
    LPG
    +4.06%
    Precision Drilling
    PDS
    +3.31%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      85.71%

    • Hold

      0.00%

    • Sell

      14.29%

    Price Target

    No Data